Becton, dickinson
Ended Awarded Last action
- Contract number
- HHSN26100036
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,330
Award facts
- Contract value 100% obligated
- $14,330.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$520 | |
| Original award | $14,850 |
About this award
Becton, Dickinson and Company, operating through its BDB Division as BD Biosciences, received a Firm Fixed Price Blanket Purchase Agreement (BPA) call contract valued at $14,330 from the National Cancer Institute on July 30, 2015, with an ultimate completion date of July 31, 2015. This contract was awarded without a set-aside designation on a full and open competition basis, with performance to be completed in Bethesda, Maryland. As a leading global medical technology company, BD Biosciences specializes in sophisticated flow cytometry systems, cell imaging technologies, and related reagents and services that support advanced biomedical research initiatives.
This BPA call represents a draw from BD Biosciences' broader Indefinite Delivery Vehicle relationships with the National Institutes of Health, which the vendor maintains to streamline procurement of specialized scientific instrumentation and consumables. The award reflects the company's established position as a prime contractor supplying flow cytometry equipment, maintenance services, and laboratory reagents to multiple federal research agencies. These technologies are critical to the National Cancer Institute's research mission, enabling cellular analysis and screening capabilities essential to cancer research and therapeutic development programs.
Quick answers
Who was awarded contract HHSN26100036?
HHSN26100036 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on July 30, 2015.
How much is contract HHSN26100036 worth?
The government has obligated $14,330 on HHSN26100036.
Is contract HHSN26100036 an order under another contract?
Yes. HHSN26100036 is a BPA call under HHSN263200600063463B, a blanket purchase agreement.
Was contract HHSN26100036 competed?
The extent of competition for HHSN26100036 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award